M
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Manozna Karri's research focuses on clinical case reports and the impact of disease and treatment on patient outcomes. Karri has investigated rare medical conditions, including inflammatory myofibroblastic tumors and drug-induced hyperprolactinemia, as documented in case reports and literature reviews. A significant area of work involves minimal residual disease (MRD) in multiple myeloma, examining its variability and dependence on molecular subgroups as defined by gene expression profiling. This research aims to understand how specific genetic markers influence clinical outcomes in patients with multiple myeloma. Karri also explores challenges in healthcare delivery, such as patient compliance in the context of telemedicine. Collaborations include work with Phillip Farmer, Hira Imad Cheema, Trilok Shrivastava, and Syed Naqvi at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 1
- Publications: 5
- Citations: 3
Selected Publications
-
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)
Collaboration Network
Top Collaborators
Arpankumar Patel
B.J. Medical College (IN)
2 shared publications
- Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
- Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case Report
Hilloni Shah
B.J. Medical College (IN)
2 shared publications
- Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
- Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case Report
Laseena Vaisyambath
Markham Stouffville Hospital (CA)
2 shared publications
- Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
- Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case Report
Appala Peela
Southeastern Health (US)
2 shared publications
- Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
- Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case Report
Thoyaja Koritala
Mayo Clinic in Florida (US)
2 shared publications
- Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
- Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case Report
Rutikbhai Desai
1 shared publication
- Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case Report
Rutikbhai Desai
B.J. Medical College (IN)
1 shared publication
- Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
Brian L. Bray
Campbell University (US)
1 shared publication
- Abstract #1165627: Risperidone induced hyperprolactinemia levels-never seen before
Kenneth McArtan
Cape Fear Valley Medical Center (US)
1 shared publication
- Abstract #1167052: Grappling with Compliance in the Telemedicine Age
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Phillip Farmer
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Clyde Bailey
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Carolina Schinke
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Samer Al Hadidi
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Maurizio Zangari
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Similar Researchers
Based on overlapping research topics
Phillip Farmer
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Telemedicine and Telehealth Implementation
Shayu Deshpande
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Telemedicine and Telehealth Implementation
Sorabh Datta
University of Arkansas for Medical Sciences
Medical Case Reports
Pharmacological Effects and Toxicity Studies
Health Disparities and Outcomes
Manuel Heredia
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Health Disparities and Outcomes
Paul W Stout
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Oluwakemi Olayinka
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Health Disparities and Outcomes